The client is a leading medical device company based in Germany, which focuses on improving patient outcomes and empowering healthcare professionals. The hospital provides patients across all areas access to quick and comfortable medical care through their advanced equipment and a complete range of services.

The diabetes analyzer device of the client experienced multiple cybersecurity vulnerabilities. The organization needed to match their security protocols with worldwide regulatory requirements because they faced three major security threats which included firmware tampering, weak encryption and data breaches that endangered their compliance status, their brand image and financial security in five different markets.

eInfochips implemented a comprehensive security strategy consisting of three main components which included firmware analysis, software composition analysis, and reverse engineering. The evaluation process revealed major security weaknesses which led to the development of fundamental solutions to fix these problems. The method decreased the healthcare regulatory approval duration by 6% and it protected financial assets. It also enhanced both their system dependability, customer confidence, and operational performance.